Site Announcement

Labcorp Enters into Agreement with OPKO Health to Acquire Select Assets of BioReference Health

OPKO Health, Inc. - Turning Scientific Innovation Into Next- Generation Medicines

OPKO Health is a biopharmaceutical company focused on developing and delivering therapeutics for serious diseases across global markets. 

Learn About Our Pipeline

We believe the future of medicine is multispecifics.

Our research is focused on advancing therapies that have the potential to impact the multifaceted components of serious conditions including cancers and infectious diseases.

Science
& Technology

Our portfolio includes multispecific antibody technologies, in vivo CAR-T delivered via antibody-guided lipid nanoparticles and proprietary long-acting peptide and protein engineering capabilities. 

Learn more

Our
Medicines

By applying next-generation technologies to well-established biological pathways, our approved therapies are designed to offer more convenient, targeted treatment options.

Learn more

Global
Operations

Our specialty pharmaceutical commercial operations manufacture and market a broad portfolio of branded and generic medicines across multiple international markets.

Learn more

Harnessing Partnerships to Advance Our Next-Generation Therapies

OPKO partners with leading biopharmaceutical companies and government agencies to accelerate the development and global reach of our therapies.

  • Pfizer
  • Merck
  • Regeneron
  • EnteraBio-Logo-new-green1.png
Learn About Our Partnerships